CanSino Biologics
Tianjin, CN · 2 known investors
Find your way into CanSino Biologics
Sign up to see every warm intro you have to CanSino Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CanSino Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CanSino Biologics develops and manufactures vaccines, including tetanus, whooping cough, pneumococcal, meningococcal, and COVID-19 vaccines for prevention of infectious diseases. The company serves healthcare systems and immunization programs, primarily in China and Asia.
Founders & leadership
HM
Helen Mao HuihuaFounder
QD
Qiu DongxuFounder
YX
Yu XuefengFounder
ZT
Zhu TaoFounder
Investors · 2
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Fortune Venture CapitalreportedShenzhen
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does CanSino Biologics do?
- CanSino Biologics develops and manufactures vaccines, including tetanus, whooping cough, pneumococcal, meningococcal, and COVID-19 vaccines for prevention of infectious diseases. The company serves healthcare systems and immunization programs, primarily in China and Asia.
- Who are CanSino Biologics's investors?
- CanSino Biologics's investors include Qiming Venture Partners, Fortune Venture Capital.
- Where is CanSino Biologics headquartered?
- CanSino Biologics is headquartered in Tianjin, CN.

